NCT04508257

The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants

Randomized, Double-blind, Parallel, Controlled Study to Evaluate the Nutritive Effects of Two Staged Infant Formulas on Growth and Cognitive Outcomes in Healthy Term Infants

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 450 (estimated)
• Sponsor: Heilongjiang Feihe Dairy Co. Ltd. · Industry
• Sex: All
• Age: 30 Days – 30 Days
• Healthy volunteers: Accepted

Summary

This study is a multicenter, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate the nutritive effects of two staged study formulas on growth and cognitive outcomes. Approximately 450 participants will be enrolled with the expectation of having 105 participants per group (315 for three groups: control group, investigational group, and breastfeeding reference group ) complete Study Visit 6 at 365 days of age ± 7 days (allowing for a 30% drop-out rate). Participants will receive stage 1 formulas up to 180 days of age and then switch to stage 2 formulas though 365 days of age. The study period will include feeding up to 365 days of age and cognitive testing up to 365 days of age. Stool samples will be collected from a subset of participants at enrollment and at 120 days of age for fecal microbiome analysis.

Detailed description

Primary Objective * Compare measures of normal, healthy mental development at 365 days of age among infants receiving an investigational formula, infants receiving the control and breastfed group. Secondary Objectives To compare between the two study groups: * Measures of mental development up to 365 days of age * Rate of body weight, length and head circumference gain * Achieved weight, length and head circumference * Stool characteristics, tolerance and formula acceptance * Fecal microbiome analysis * Antibiotic treatment * Medically-confirmed adverse

Conditions

• Child Development

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Oral feeding of Investigational Formula (Stage 1&2)	Participants will receive stage 1 formulas up to 180 days of age and then switch to stage 2 formulas though 365 days of age.
DIETARY_SUPPLEMENT	Oral feeding of Control formula (Stage 1&2)	Participants will receive stage 1 formulas up to 180 days of age and then switch to stage 2 formulas though 365 days of age.
DIETARY_SUPPLEMENT	Breast feeding	Exclusively breastfed for the first 4 months and continue with supplement food without any marketed infant formula.

Timeline

• Start date: 2020-08-01
• Primary completion: 2023-02-28
• Completion: 2023-02-28
• First posted: 2020-08-11
• Last updated: 2020-08-18

Locations

3 sites across 1 country: China